Integra LifeSciences (IART) Tops Q2 EPS by 7c, Revenues Beat; Raises FY19 EPS Guidance, Affirms FY19 Revenue Outlook
Tweet Send to a Friend
Integra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.73, $0.07 better than the analyst estimate of $0.66. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
